RESUMO
OBJECTIVE: Differences in patients and nurses' perceptions of caring behaviors arouse patient dissatisfaction. Continuous monitoring and assessment of caring behaviors has revealed its problems, and this in turn would promote care services by planning rational interventions and removing the problems. The present study aimed to compare nurses and elderly patients' perceptions of nurses' caring behaviors in intensive care units in accordance with Watson's transpersonal caring theory. METHODS: In this descriptive-analytical study, 70 nurses were selected using the census method, and 70 elderly patients over 60 years old were also selected using purposive sampling method from the intensive care units of Lorestan University of Medical Sciences during 2012-2013. Caring Behavior Inventory for Elders (CBI-E) was adopted in this research to detect the nurses and elderly patients' perceptions of caring behaviors. In the data analysis phase, Kruskal-Wallis, Mann-Whitney U, and Pearson correlation tests were used. RESULTS: The research findings revealed no statistically significant difference between the total scores of nurses' 83.80 (22.93), 95% CI [78.40, 89.20] and elderly patients' 80.09 (26.00), 95% CI [74, 86.20] perception of nurses' caring behaviors (P=0.379). From the viewpoint of the nurses and elderly patients, responding quickly to a patient's call 100.00 (0.00), 95% CI [100.00, 100.00] had the highest mean scores and patient participation in caring process had the lowest mean scores among nurses 22.86 (33.71), 95% CI [15.00, 30.80] and elderly patients 14.29 (28.41), 95% CI [7.63, 20.90]. CONCLUSION: This study indicated the elderlies and nurses' similar perceptions of caring behaviors in intensive care units. This finding would help nurses to recognize and prioritize the elderly patients' care needs, thereby promoting the quality of care services.
Assuntos
Enfermeiras e Enfermeiros , Pacientes , Humanos , Idoso , Pessoa de Meia-Idade , Unidades de Terapia IntensivaRESUMO
OBJECTIVE: The grieving process in parents of these children is an ongoing and cyclic one since there is no real end to it. We explored the experience of grief and feelings of loss in fathers of children diagnosed with autism spectrum disorder (ASD), in the west and northwest of Iran. MATERIALS AND METHODS: This qualitative study was conducted using content analysis. Fourteen fathers took part in a semi-structured interview. RESULTS: Six categories were identified in relation to the stages of grief: 1- "Uncertainty of dealing with the unpleasant unknown"; 2- "Being hurt and broken inside"; 3- "Isolation and concealment as a consequence of the pressure caused by ignorance"; 4- "Search for cause"; 5- "Search for a cure"; 6- "Breaking or blooming". CONCLUSIONS: Fathers of children with ASD go through intense and continuous sorrow and grief. According to our findings, it is recommended that health care professionals work collaboratively with fathers and provide support upon receiving the diagnosis of their child.
Assuntos
Transtorno do Espectro Autista , Pai/psicologia , Pesar , Adolescente , Adulto , Transtorno do Espectro Autista/terapia , Criança , Pré-Escolar , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Irã (Geográfico) , Masculino , Pessoa de Meia-Idade , Pesquisa Qualitativa , Estresse PsicológicoRESUMO
INTRODUCTION: Sensory nerves of the tooth pulp have been evolved in both deciduous and permanent teeth for conducting possible damages to the teeth. Although it has been reported that the deciduous tooth's pulp is histologically similar to permanent teeth, the difference in the density of nerves between the first and second deciduous molars has been reported in no studies. AIM: The aim of the study was to investigate the histological assay of pulpal nerves and assess the relationship between diameter and density of nerve fibres in the first and second deciduous molar teeth. MATERIALS AND METHODS: In this in vitro study, 15 deciduous first and 16 deciduous second extracted from molar teeth belonging to children aged from 5 to 8 years were studied. After fixation, the decalcified teeth were sectioned and then stained with silver solution and calcitonin gene-related peptide (CGRP) antibody. The mean diameter of myelinated fibres, un-myelinated fibres, and density of peripheral network fibres of dental pulp were examined. RESULTS: The results showed that the mean diameter of myelinated and non-myelinated fibres and density of nerve fibres were significantly more in the second molars (4.269, 2.328 µm, 2.6 fibres per unit area) compared to the first molar teeth (3.793, 2.093 µm, 1.8 fibres per unit area) (P < 0.032, 0.019, 0.003, respectively). An important finding in this study, which is reported for the first time, is the presence of fatty cells (adipocytes) in pulp tissue of some of the first deciduous molars as well as the second molars. CONCLUSIONS: Based on the results of the current study, differences between nerve fibres of first and second molar teeth are significant. It could be concluded that the less sensitivity to pain of the first deciduous molars compared with the second deciduous molars, is due to the lower nerve density of this tooth.
Assuntos
Polpa Dentária , Dente Molar , Idoso , Peptídeo Relacionado com Gene de Calcitonina , Criança , Humanos , Fibras Nervosas , Raiz Dentária , Dente DecíduoRESUMO
Morton's neuromas are benign lesions of the inter-digital nerves within the foot. They are most commonly found in the second and third webspace. Morton's neuroma of the first webspace is very rare. A case of a 42-year-old female who presented complaining of long standing forefoot pain is presented. The patient was diagnosed with a soft tissue tumor in the 1st webspace. An excisional biopsy of the tumour confirmed a Morton's neuroma. Very few cases of Morton's neuroma in the first webspace have been reported in the literature.
Assuntos
Neuroma Intermetatársico/diagnóstico , Neuroma Intermetatársico/cirurgia , Adulto , Feminino , HumanosRESUMO
BACKGROUND AND PURPOSE: The aim was to study the prevalence of epilepsy in a hospital-based systemic lupus erythematosus (SLE) cohort and to investigate the relationship between epilepsy and other manifestations of neuropsychiatric SLE (NPSLE). METHODS: The study population consisted of 440 SLE patients recruited from 1998 to 2012. An epilepsy-screening questionnaire was sent to all patients, where those screening positive were invited to a neurological examination with documentation of NPSLE symptoms according to the American College of Rheumatology nomenclature. Occurrences of autoantibodies (double stranded DNAantibody, antinuclear antibody, lupus anticoagulant, Sjögren's syndrome A, Sjögren's syndrome B) and the antiphospholipid syndrome (APS) were tabulated. RESULTS: Out of 440 patients, 14% were dead and 2.7% were lost to follow-up. The questionnaire was sent to 368 patients; 312 (85%) responded. Of these, 131 (42%) screened positive. Epilepsy was confirmed in 36 (11.5%), of whom 30 (83%) had focal onset. Ten (3.2%) patients had isolated or provoked seizures. Manifestations of NPSLE occurred in 50%. The rates of cerebrovascular disease and psychosis were elevated two- and three-fold in NPSLE patients with epilepsy versus NPSLE patients without epilepsy, respectively (P = 0.001 and P = 0.0006). APS was more common in patients with epilepsy compared to epilepsy-free SLE patients with or without NPSLE (P = 0.02). In 50% of patients with epilepsy, no other etiology than SLE was detected. CONCLUSIONS: A high prevalence of epilepsy in SLE patients is reported, with association to concurrent cerebrovascular disease, APS and psychosis. Our findings support the notion of a multifactorial background for epilepsy in SLE including both vascular disease and features consistent with autoimmunity.
Assuntos
Epilepsia , Lúpus Eritematoso Sistêmico , Epilepsia/epidemiologia , Epilepsia/etiologia , Humanos , Lúpus Eritematoso Sistêmico/complicações , Lúpus Eritematoso Sistêmico/epidemiologia , Prevalência , Fatores de RiscoRESUMO
BACKGROUND: Type 1 narcolepsy is a neurological disorder characterized by excessive daytime sleepiness and cataplexy associated with the HLA allele DQB1*06:02. Genetic predisposition along with external triggering factors may drive autoimmune responses, ultimately leading to the selective loss of hypocretin-positive neurons. OBJECTIVE: The aim of this study was to investigate potential aetiological factors in Swedish cases of postvaccination (Pandemrix) narcolepsy defined by interferon-gamma (IFNγ) production from immune cells in response to molecularly defined targets. METHODS: Cellular reactivity defined by IFNγ production was examined in blood from 38 (HLA-DQB1*06:02(+) ) Pandemrix-vaccinated narcolepsy cases and 76 (23 HLA-DQB1*06:02(+) and 53 HLA-DQB1*06:02(-) ) control subjects, matched for age, sex and exposure, using a variety of different antigens: ß-haemolytic group A streptococcal (GAS) antigens (M5, M6 and streptodornase B), influenza (the pandemic A/H1N1/California/7/09 NYMC X-179A and A/H1N1/California/7/09 NYMC X-181 vaccine antigens, previous Flu-A and -B vaccine targets, A/H1N1/Brisbane/59/2007, A/H1N1/Solomon Islands/3/2006, A/H3N2/Uruguay/716/2007, A/H3N2/Wisconsin/67/2005, A/H5N1/Vietnam/1203/2004 and B/Malaysia/2506/2004), noninfluenza viral targets (CMVpp65, EBNA-1 and EBNA-3) and auto-antigens (hypocretin peptide, Tribbles homolog 2 peptide cocktail and extract from rat hypothalamus tissue). RESULTS: IFN-γ production was significantly increased in whole blood from narcolepsy cases in response to streptococcus serotype M6 (P = 0.0065) and streptodornase B protein (P = 0.0050). T-cell recognition of M6 and streptodornase B was confirmed at the single-cell level by intracellular cytokine (IL-2, IFNγ, tumour necrosis factor-alpha and IL-17) production after stimulation with synthetic M6 or streptodornase B peptides. Significantly, higher (P = 0.02) titres of serum antistreptolysin O were observed in narcolepsy cases, compared to vaccinated controls. CONCLUSION: ß-haemolytic GAS may be involved in triggering autoimmune responses in patients who developed narcolepsy symptoms after vaccination with Pandemrix in Sweden, characterized by a Streptococcus pyogenes M-type-specific IFN-γ cellular immune response.
Assuntos
Narcolepsia/imunologia , Streptococcus agalactiae/imunologia , Estreptodornase e Estreptoquinase/imunologia , Adolescente , Adulto , Idoso , Antiestreptolisina/sangue , Criança , Feminino , Humanos , Interferon gama/biossíntese , Interferon gama/sangue , Masculino , Pessoa de Meia-Idade , Narcolepsia/epidemiologia , Fragmentos de Peptídeos/biossíntese , Fragmentos de Peptídeos/sangue , Sorotipagem , Streptococcus agalactiae/enzimologia , Suécia/epidemiologiaRESUMO
BACKGROUND AND OBJECTIVE: We explored which clinical and biochemical variables predict conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS) in a large international cohort. METHODS: Thirty-three centres provided serum samples from 1047 CIS cases with at least two years' follow-up. Age, sex, clinical presentation, T2-hyperintense lesions, cerebrospinal fluid (CSF) oligoclonal bands (OCBs), CSF IgG index, CSF cell count, serum 25-hydroxyvitamin D3 (25-OH-D), cotinine and IgG titres against Epstein-Barr nuclear antigen 1 (EBNA-1) and cytomegalovirus were tested for association with risk of CDMS. RESULTS: At median follow-up of 4.31 years, 623 CIS cases converted to CDMS. Predictors of conversion in multivariable analyses were OCB (HR = 2.18, 95% CI = 1.71-2.77, p < 0.001), number of T2 lesions (two to nine lesions vs 0/1 lesions: HR = 1.97, 95% CI = 1.52-2.55, p < 0.001; >9 lesions vs 0/1 lesions: HR = 2.74, 95% CI = 2.04-3.68, p < 0.001) and age at CIS (HR per year inversely increase = 0.98, 95% CI = 0.98-0.99, p < 0.001). Lower 25-OH-D levels were associated with CDMS in univariable analysis, but this was attenuated in the multivariable model. OCB positivity was associated with higher EBNA-1 IgG titres. CONCLUSIONS: We validated MRI lesion load, OCB and age at CIS as the strongest independent predictors of conversion to CDMS in this multicentre setting. A role for vitamin D is suggested but requires further investigation.
Assuntos
Esclerose Múltipla/patologia , Adulto , Estudos de Coortes , Progressão da Doença , Endonucleases , Feminino , Seguimentos , Humanos , Imunoglobulina G/análise , Imageamento por Ressonância Magnética , Masculino , Esclerose Múltipla/líquido cefalorraquidiano , Proteínas Nucleares/análise , Bandas Oligoclonais/genética , Valor Preditivo dos Testes , Prognóstico , Medição de Risco , Análise de Sobrevida , Vitamina D/sangueRESUMO
Introduction: Hepatitis has involved many individuals and has left many complications. Hepatitis C is a type of hepatitis connected with several dilemmas. The purpose of the research is to study the Hepatitis epidemiology C into the Island of Qeshm in 2014. Method: this was an interventional study conducted on 1500 inhabitants of Qeshm Island. Participants were selected by using cluster sampling. Five cc of blood was drawn from each participant in order to test for HCV-Ab with ELIZA technique. Positive samples were referred for PCR to investigate the presence of anti Hepatitis C anti body. Data were entered in SPSS v.16 after sample collection and are examined utilizing detailed census (prevalence, mean, percent and standard deviation) and chi-square. Results: out of 1500 participants, 986 (65.7%) are women and 514 (34.3 %) are men. HCV anti body was seen in four patients (0.3 percent). The outcomes of the research explained that not of the studied factors (age, gender, marital status, place of residence, educational level, history of IV drug abuse, being in jail, quitting addiction, risky sexual behavior, etc.) is related to antibody pervasiveness. Conclusion: The disease pervasiveness was 0.3 percent in Qeshm Island, that is compatible with the another research outcomes. Also, factors investigated for HCV were not recognized as HCV risk factors.
RESUMO
OBJECTIVE: The objective of this report is to assess the presence and viral load of JC polyomavirus (JCV) DNA in cerebrospinal fluid (CSF) and plasma from neuropsychiatric systemic lupus erythematosus (NPSLE) patients in comparison to controls and to investigate if different types of immunosuppressive treatments were correlated to detection and viral load of JCV DNA in SLE. BACKGROUND: Reactivation of a latent JCV infection with subsequent development of the fatal disease progressive multifocal leukoencephalopathy (PML) has become an increasing problem in patients with autoimmune diseases treated with newer immunosuppressants. Accumulating data point out that SLE patients are at particular risk for PML compared to patients with other rheumatic diseases. METHODS: CSF samples (n = 69) and plasma samples (n = 51) from 71 SLE patients and 58 controls (53 CSF samples and 50 plasma samples) with other non-inflammatory neurological disease (OND) were analyzed for JCV DNA with a quantitative PCR method. RESULTS: All CSF and plasma samples from NPSLE patients and controls were negative for JCV DNA. CONCLUSION: JCV DNA was absent in CSF and plasma in NPSLE patients and controls and consequently we were not able to identify any correlation between the occurrence of JCV DNA and type of immunosuppressive medication.
Assuntos
DNA Viral/análise , Fatores Imunológicos/uso terapêutico , Vírus JC/genética , Leucoencefalopatia Multifocal Progressiva/etiologia , Vasculite Associada ao Lúpus do Sistema Nervoso Central/virologia , Adulto , Idoso , DNA Viral/líquido cefalorraquidiano , DNA Viral/urina , Feminino , Humanos , Fatores Imunológicos/efeitos adversos , Leucoencefalopatia Multifocal Progressiva/virologia , Vasculite Associada ao Lúpus do Sistema Nervoso Central/terapia , Masculino , Pessoa de Meia-Idade , Carga Viral , Adulto JovemRESUMO
BACKGROUND: The mechanisms of multiple sclerosis (MS) pathogenesis are still largely unknown. The heterogeneity of disease manifestations make the prediction of prognosis and choice of appropriate treatment protocols challenging. Recently, increased cerebrospinal fluid (CSF) levels of the B-cell chemokine CXCL13 was proposed as a possible marker for a more severe disease course and conversion from clinically isolated syndrome (CIS) to relapsing-remitting MS (RRMS). OBJECTIVE: To investigate whether there are genetic susceptibility variants in MS that correlate with the levels of CXCL13 present in the CSF of MS patients. METHODS: We genotyped the human leukocyte antigens HLA-DRB1 and HLA-A, plus a panel of single nucleotide polymorphisms (SNPs) that have been associated with susceptibility to MS and then correlated the genotypes with the levels of CXCL13, as measured with ELISA in the CSF of a total of 663 patients with MS, CIS, other neurological diseases (OND) or OND with an inflammatory component (iOND). RESULTS: Presence of the HLA-DRB1*15 and the MS risk genotypes for SNPs in the RGS1, IRF5 and OLIG3/TNFAIP3 gene regions correlated significantly with increased levels of CXCL13. CONCLUSION: Our results pointed towards a genetic predisposition for increased CXCL13 levels, which in MS patients correlates with the severity of the disease course. These findings encourage further investigation and replication, in an independent patient cohort.
Assuntos
Quimiocina CXCL13/líquido cefalorraquidiano , Predisposição Genética para Doença/genética , Esclerose Múltipla/líquido cefalorraquidiano , Esclerose Múltipla/genética , Biomarcadores/líquido cefalorraquidiano , Ensaio de Imunoadsorção Enzimática , Genótipo , Antígenos HLA-A/genética , Cadeias HLA-DRB1/genética , Humanos , Polimorfismo de Nucleotídeo Único , Prognóstico , Fatores de Risco , TranscriptomaRESUMO
Expression of the forkhead box protein 3 (FoxP3) transcription factor is regulated by the E3 ubiquitin ligases Itch and Cbl-b and induces regulatory activity CD4(+) CD25(high) T cells. Treatment with interferon (IFN)-ß enhances regulatory T cell activity in multiple sclerosis (MS). We studied the phenotype of CD4(+) CD25(high) T cells in MS by flow cytometry and its relationship with expression of the FOXP3, ITCH and CBLB genes. We found that untreated MS patients had lower cell surface expression of cytotoxic T lymphocyte antigen 4 (CTLA-4) on CD4(+) CD25(high) T cells and higher intracellular CTLA-4 expression than healthy controls. Cell surface expression of CTLA-4 on CD4(+) CD25(high) T cells correlated with expression of FOXP3 mRNA in untreated patients and increased significantly with time from most recent injection in patients treated with IFN-ß. FOXP3 mRNA expression correlated with CBLB and ITCH and T helper type 2 cytokine mRNA expression in MS patients. These data link expression of FOXP3, CBLB and ITCH mRNA and CTLA-4 expression on the surface of CD4(+) CD25(high) T cell in MS. We hypothesize that this may reflect alterations in the inhibitory effect of CTLA-4 or in regulatory T cell function.
Assuntos
Proteínas Adaptadoras de Transdução de Sinal/genética , Linfócitos T CD4-Positivos/imunologia , Antígeno CTLA-4/genética , Fatores de Transcrição Forkhead/genética , Subunidade alfa de Receptor de Interleucina-2/genética , Esclerose Múltipla/genética , Proteínas Proto-Oncogênicas c-cbl/genética , Proteínas Repressoras/genética , Ubiquitina-Proteína Ligases/genética , Proteínas Adaptadoras de Transdução de Sinal/biossíntese , Proteínas Adaptadoras de Transdução de Sinal/imunologia , Adulto , Antígeno CTLA-4/biossíntese , Antígeno CTLA-4/imunologia , Feminino , Fatores de Transcrição Forkhead/biossíntese , Fatores de Transcrição Forkhead/imunologia , Expressão Gênica/imunologia , Humanos , Interferon beta/biossíntese , Interferon beta/genética , Interferon beta/imunologia , Subunidade alfa de Receptor de Interleucina-2/biossíntese , Subunidade alfa de Receptor de Interleucina-2/imunologia , Masculino , Esclerose Múltipla/imunologia , Proteínas Proto-Oncogênicas c-cbl/biossíntese , Proteínas Proto-Oncogênicas c-cbl/imunologia , RNA Mensageiro/genética , RNA Mensageiro/imunologia , Proteínas Repressoras/biossíntese , Proteínas Repressoras/imunologia , Ubiquitina-Proteína Ligases/biossíntese , Ubiquitina-Proteína Ligases/imunologiaRESUMO
Multiple sclerosis (MS) patients, with a second autoimmune disease after lymphocyte depletion, had elevated serum IL-21 before and after treatment which correlated to IL21 genotypes. In addition, the IL21 gene has been associated to several other autoimmune diseases. However, in a Spanish population there was no association to MS. Here, in a Swedish cohort (2090 MS cases and 1732 controls) 12 single nucleotide polymorphisms (SNPs) tagging IL21 were not associated to disease. There was no interaction with risk alleles of IL21R and HLA-DRB1*15. Lack of genetic association was confirmed in a meta-analysis with pooled data from the present study and the Spanish study. In conclusion, IL21 has not been shown to be a major risk gene for MS.
Assuntos
Cadeias HLA-DRB1/genética , Subunidade alfa de Receptor de Interleucina-21/genética , Interleucinas/genética , Esclerose Múltipla/genética , Polimorfismo de Nucleotídeo Único , Alelos , Estudos de Coortes , Epistasia Genética , Feminino , Predisposição Genética para Doença , Humanos , Masculino , Fatores de Risco , SuéciaRESUMO
OBJECTIVE: To study the longitudinal dynamics of anti-myelin oligodendrocyte glycoprotein (MOG) autoantibodies in childhood demyelinating diseases. METHODS: We addressed the kinetics of anti-MOG immunoglobulins in a prospective study comprising 77 pediatric patients. This was supplemented by a cross-sectional study analyzing 126 pediatric patients with acute demyelination and 62 adult patients with multiple sclerosis (MS). MOG-transfected cells were used for detection of antibodies by flow cytometry. RESULTS: Twenty-five children who were anti-MOG immunoglobulin (Ig) positive at disease onset were followed for up to 5 years. Anti-MOG antibodies rapidly and continuously declined in all 16 monophasic patients with acute disseminated encephalomyelitis and in one patient with clinically isolated syndrome. In contrast, in 6 of 8 patients (75%) eventually diagnosed with childhood MS, the antibodies to MOG persisted with fluctuations showing a second increase during an observation period of up to 5 years. Antibodies to MOG were mainly IgG 1 and their binding was largely blocked by pathogenic anti-MOG antibodies derived from a spontaneous animal model of autoimmune encephalitis. The cross-sectional part of our study elaborated that anti-MOG Ig was present in about 25% of children with acute demyelination, but in none of the pediatric or adult controls. Sera from 4/62 (6%) adult patients with MS had anti-MOG IgG at low levels. CONCLUSIONS: The persistence or disappearance of antibodies to MOG may have prognostic relevance for acute childhood demyelination.
Assuntos
Autoanticorpos/análise , Encefalomielite Aguda Disseminada/imunologia , Glicoproteína Associada a Mielina/imunologia , Adolescente , Adulto , Ligação Competitiva , Linhagem Celular , Criança , Pré-Escolar , Estudos de Coortes , Estudos Transversais , Feminino , Citometria de Fluxo , Humanos , Imunoglobulina G/análise , Imunoglobulinas/análise , Lactente , Cinética , Estudos Longitudinais , Masculino , Esclerose Múltipla/imunologia , Esclerose Múltipla/metabolismo , Proteínas da Mielina , Glicoproteína Mielina-Oligodendrócito , Estudos Prospectivos , TransfecçãoRESUMO
OBJECTIVES: A proliferation-inducing ligand (APRIL) and B-cell activation factor (BAFF) are B-cell stimulation and survival molecules. We have investigated whether APRIL and/or BAFF activity is enhanced in the systemic and/or intrathechal compartment of patients with neuropsychiatric systemic lupus erythematosus (NPSLE). In particular, the association between fatigue and APRIL/BAFF activity was investigated. METHODS: Twenty-eight NPSLE patients were evaluated clinically, with sampling of cerebrospinal fluid (CSF) and blood, and magnetic resonance imaging (MRI). CSF and blood samples from 13 multiple sclerosis (MS) patients and 17 patients with other neurological diseases (OND) were used as controls. Protein levels of BAFF and APRIL were quantified in CSF and plasma, mRNA expression levels of BAFF and APRIL were determined in peripheral blood (PBMC) and CSF mononuclear cells (CSF-MC). The Fatigue Severity Scale (FSS) was used to quantify the degree of fatigue. RESULTS: NPSLE patients had higher levels of APRIL in CSF as compared to OND (p < 0.01). No corresponding increase in APRIL mRNA levels was detected in CSF-MC. BAFF levels in plasma were higher in NPSLE than in OND (p < 0.001). BAFF mRNA expression in PBMC was also higher in NPSLE patients than in controls (p < 0.05). FSS scores in patients with NPSLE correlated significantly with APRIL levels in CSF. CONCLUSIONS: Protein levels of APRIL in CSF were increased in NPSLE as compared to OND. Moreover, there was a positive correlation between CSF APRIL levels and fatigue. Our results suggest that APRIL and possibly also BAFF may be involved in the pathogenesis of NPSLE and in SLE-related fatigue.
Assuntos
Vasculite Associada ao Lúpus do Sistema Nervoso Central/líquido cefalorraquidiano , Membro 13 da Superfamília de Ligantes de Fatores de Necrose Tumoral/líquido cefalorraquidiano , Adolescente , Adulto , Idoso , Fator Ativador de Células B/sangue , Fator Ativador de Células B/líquido cefalorraquidiano , Estudos de Coortes , Estudos Transversais , Fadiga/sangue , Fadiga/líquido cefalorraquidiano , Feminino , Humanos , Leucócitos Mononucleares/química , Vasculite Associada ao Lúpus do Sistema Nervoso Central/sangue , Masculino , Pessoa de Meia-Idade , Membro 13 da Superfamília de Ligantes de Fatores de Necrose Tumoral/sangue , Adulto JovemRESUMO
OBJECTIVES: A common nonsynonymous single nucleotide polymorphism (SNP) in the CD93 gene (rs3746731, Pro541Ser) has been associated with risk of coronary artery disease (CAD). CD93 is a transmembrane glycoprotein, which is detectable in soluble form in human plasma. We investigated whether the concentration of soluble CD93 in plasma is related to risk of myocardial infarction (MI) and CAD, using a case-control study of premature MI (n = 764) and a nested case-control analysis of a longitudinal cohort study of 60-year-old subjects (analysis comprising 844 of 4232 subjects enrolled at baseline). In addition, SNPs in the CD93 gene were studied in relation to plasma CD93 concentration and CD93 mRNA expression. METHODS AND RESULTS: A sensitive and specific enzyme-linked immunosorbent assay was established for determination of the plasma CD93 concentration. Subjects were divided into three groups according to tertiles of the distribution of CD93 concentration. Lower odds ratios for risk of MI and incidence of CAD were observed in the middle CD93 tertile (142-173 µg L(-1) ): odds ratio (95% confidence interval), 0.69 (0.49-0.97) and 0.61 (0.40-0.94), respectively. These associations were independent of traditional CAD risk factors. The minor allele of a SNP in the 3' untranslated region of CD93 (rs2749812) was associated with increased plasma CD93 concentrations (P = 0.03) and increased CD93 mRNA expression levels (P = 0.02). CONCLUSION: The results of the present study suggest that the concentration of soluble CD93 in plasma is a potential novel biomarker for CAD, including MI.
Assuntos
Doença da Artéria Coronariana/sangue , Doença da Artéria Coronariana/genética , Glicoproteínas de Membrana/sangue , Glicoproteínas de Membrana/genética , Polimorfismo de Nucleotídeo Único , Receptores de Complemento/sangue , Receptores de Complemento/genética , Idoso , Biomarcadores/sangue , Estudos de Casos e Controles , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/sangue , Infarto do Miocárdio/genética , Razão de Chances , Valor Preditivo dos Testes , Prolina , Estudos Prospectivos , RNA Mensageiro/sangue , Medição de Risco , Fatores de Risco , SerinaRESUMO
15-Oxygenated cholesterol species such as 5α-cholest-8(14)ene-3ß,15α-diol (15HC) and 3ß-hydroxy-5α-cholest-8(14)-en-15-one (15KC) are commercially available synthetic products unlikely to occur in biological systems. Surprisingly, Farez et al. recently reported that these two steroids occur in human circulation at levels considerably higher than those of any other endogenous oxysterol [Farez, M. et al. 2009. Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nat. Immunol. 10: 958-964]. The levels were reported to be increased in patients with multiple sclerosis in a progressive phase and the authors suggested that this could be utilized diagnostically. Based on extensive in vitro experiments exposing cells to the same high levels of 15HC as found in vivo (1000 ng/ml) the authors concluded that 15HC may be an important pathogenetic factor in multiple sclerosis. Using combined gas chromatography-mass spectrometry we fail to detect significant plasma levels of 15HC either in healthy controls or in patients with multiple sclerosis (levels < 2 ng/ml). If 15KC is present in these plasma samples, the concentration of it must be <10 ng/ml. Our failure to detect significant levels of the above steroids could not be due to loss during hydrolysis and work-up because recovery of the added two oxysterols was close to 100%. Autoxidation of lipoprotein-bound cholesterol resulted in extensive conversion of cholesterol into 7-oxygenated but not 15-oxygenated sterols. We conclude that if present there are trace amounts only of the above 15-oxygenated steroids in human circulation and that the role of such oxysterols as pathogenetic factors and biomarkers must be reconsidered.
Assuntos
Colestenonas/sangue , Hidroxicolesteróis/sangue , Esclerose Múltipla/sangue , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Oxirredução , Oxigênio/metabolismoRESUMO
Rat chromosome 1 harbors overlapping quantitative trait loci (QTL) for cytokine production and experimental models of inflammatory diseases. We fine-dissected this region that regulated cytokine production, myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE), anti-MOG antibodies and pristane-induced arthritis (PIA) in advanced intercross lines (AILs). Analysis in the tenth and twelfth generation of AILs resolved the region in two narrow QTL, Eae30 and Eae31. Eae30 showed linkage to MOG-EAE, anti-MOG antibodies and levels of interleukin-6 (IL-6). Eae31 showed linkage to EAE, PIA, anti-MOG antibodies and levels of tumor necrosis factor (TNF) and IL-6. Confidence intervals defined a limited set of potential candidate genes, with the most interesting being RGMA, IL21R and IL4R. We tested the association with multiple sclerosis (MS) in a Nordic case-control material. A single nucleotide polymorphism in RGMA associated with MS in males (odds ratio (OR)=1.33). Polymorphisms of RGMA also correlated with changes in the expression of interferon-gamma (IFN-gamma) and TNF in cerebrospinal fluid of MS patients. In IL21R, there was one positively associated (OR=1.14) and two protective (OR=0.87 and 0.68) haplotypes. One of the protective haplotypes correlated to lower IFN-gamma expression in peripheral blood mononuclear cells of MS patients. We conclude that RGMA and IL21R and their pathways are crucial in MS pathogenesis and warrant further studies as potential biomarkers and therapeutic targets.
Assuntos
Encefalomielite Autoimune Experimental/genética , Proteínas de Membrana/genética , Esclerose Múltipla/genética , Proteínas do Tecido Nervoso/genética , Receptores de Interleucina-21/genética , Animais , Feminino , Proteínas Ligadas por GPI , Ligação Genética , Haplótipos , Masculino , Polimorfismo de Nucleotídeo Único , Locos de Características Quantitativas , RatosRESUMO
BACKGROUND: Accumulating evidence supports a major role of B cells in multiple sclerosis (MS) pathogenesis. How B cells are recruited to the CNS is incompletely understood. Our objective was to study B-cell chemokine concentrations in MS, their relationship with disease activity, and how treatment with methylprednisolone and natalizumab affected the concentration in CSF. METHODS: Using a cross-sectional design, CSF and blood samples were obtained from cohorts of patients with clinically isolated syndromes (CIS), relapsing-remitting MS (RRMS), primary progressive MS (PPMS), or secondary progressive MS (SPMS), and noninflammatory neurologic disease control subjects. Some patients with RRMS were studied before and after treatment with methylprednisolone or natalizumab. RESULTS: In CSF, concentrations of CXCL13, but not CXCL12, were higher in patients with CIS, RRMS, SPMS, and PPMS than in controls. CSF concentrations of CXCL13 correlated with the CSF B-cell count, with markers of immune activation, and with disease activity in patients with CIS and RRMS. CSF concentrations of CXCL13 decreased after treatment with high-dose methylprednisolone and natalizumab. High CSF concentrations of CXCL13 correlated with low expression of messenger RNA encoding the immunoregulatory cytokines interleukin 10 and transforming growth factor beta1, but not with the expression of T-helper type 1 (Th1) and Th17 factors. CONCLUSION: The chemokine CXCL13 may play a major role in recruitment of B cells and T-cell subsets expressing the chemokine receptor CXCR5 to the CNS in multiple sclerosis (MS), and may be a useful biomarker for treatment effects in MS. Furthermore, CXCL13 or its receptor CXCR5 should be considered as therapeutic targets in MS.
Assuntos
Quimiocina CXCL13/líquido cefalorraquidiano , Esclerose Múltipla/líquido cefalorraquidiano , Adulto , Idoso , Linfócitos B/metabolismo , Linfócitos B/patologia , Biomarcadores/sangue , Biomarcadores/líquido cefalorraquidiano , Quimiocina CXCL13/sangue , Estudos de Coortes , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Esclerose Múltipla/sangue , Esclerose Múltipla/classificação , Esclerose Múltipla/patologia , Transporte Proteico/fisiologia , Receptores CXCR5/biossíntese , Receptores CXCR5/sangue , Subpopulações de Linfócitos T/metabolismo , Subpopulações de Linfócitos T/patologiaRESUMO
OBJECTIVE: Axonal degeneration is the likely cause of disease progression in multiple sclerosis (MS). Our previous results indicated that neuron-specific N-acetylaspartate (NAA) is a candidate CSF biomarker for disease progression in MS. The aim of this study was to explore the potential of NAA as an early biomarker of axonal damage in MS. Next, we wanted to know the additional value of measurement of NAA compared to other candidate markers for axonal damage, such as neurofilament subunits and tau protein. METHODS: Levels of NAA, neurofilament light, neurofilament heavy, and tau were determined in CSF of patients with clinically isolated syndrome (CIS, n = 38), relapsing-remitting MS (RRMS, n = 42), secondary progressive MS (SPMS, n = 28), and primary progressive MS (PPMS, n = 6); patients without neurologic disease (ND, n = 28); noninflammatory neurologic controls (n = 18); and inflammatory neurologic controls (n = 39). RESULTS: CSF NAA levels were decreased in patients with SPMS compared to ND controls, patients with CIS, and patients with RRMS. CSF NAA levels in patients with CIS and RRMS were similar to those in ND subjects. All axonal damage proteins showed specific patterns of changes and relations with disease activity measures. The neurofilament light chain levels were already increased in patients with CIS, especially in patients who converted to MS. The neurofilament heavy chain levels were highest in the patients with SPMS. Tau levels were similar in MS and ND. CONCLUSIONS: CSF N-acetylaspartate (NAA) levels were not different from patients without neurologic disease in early stages of multiple sclerosis, though decreased as the disease progressed. Combining CSF NAA and neurofilament levels yields information on different phases of axonal pathology.